Antibiotic Exposure and Risk for Death or Bronchopulmonary Dysplasia in Very Low Birth Weight Infants

Journal of Pediatrics

Volumn 181, Issue , 2017, Pages 289-293.e1

  Cantey, Joseph B ^a   Huffman, Landon W ^a   Subramanian, Abirami ^a   Marshall, Anderson S ^a   Ballard, A Rebecca ^a   Lefevre, Cassandra ^a   Sagar, Malvika ^a   Pruszynski, Jessica E ^b   Mallett, Lea H ^a  

^a TEXAS A AND M HEALTH SCIENCE CENTER   (United States)

^b SCOTT AND WHITE MEMORIAL HOSPITAL   (United States)

Author keywords

Neonatal intensive care unit; Neonate

Indexed keywords

AMPICILLIN; ANTIBIOTIC AGENT; GENTAMICIN; PIPERACILLIN PLUS TAZOBACTAM; VANCOMYCIN; ANTIINFECTIVE AGENT;

ANTIBIOTIC THERAPY; ARTICLE; ARTIFICIAL VENTILATION; CHORIOAMNIONITIS; COHORT ANALYSIS; FEMALE; GESTATIONAL AGE; HUMAN; INFANT; INTRAUTERINE GROWTH RETARDATION; LUNG DYSPLASIA; MAJOR CLINICAL STUDY; MALE; MATERNAL AGE; PRENATAL DRUG EXPOSURE; PRIORITY JOURNAL; PROSPECTIVE STUDY; RETROSPECTIVE STUDY; VAGINAL DELIVERY; VERY LOW BIRTH WEIGHT; BRONCHOPULMONARY DYSPLASIA; MORTALITY; NEONATAL INTENSIVE CARE UNIT; NEWBORN; RISK FACTOR;

ANTI-BACTERIAL AGENTS; BRONCHOPULMONARY DYSPLASIA; COHORT STUDIES; FEMALE; HUMANS; INFANT, NEWBORN; INFANT, VERY LOW BIRTH WEIGHT; INTENSIVE CARE UNITS, NEONATAL; MALE; RETROSPECTIVE STUDIES; RISK FACTORS;

EID: 85007502837     PISSN: 00223476     EISSN: 10976833     Source Type: Journal    
DOI: 10.1016/j.jpeds.2016.11.002     Document Type: Article

References (31)

1. 1 Stoll, B.J., Hansen, N.I., Bell, E.F., Walsh, M.C., Carlo, W.A., Shankaran, S., et al. Trends in care practices, morbidity, and mortality of extremely preterm neonates, 1993-2012. JAMA 314 (2015), 1039–1051.
2. 2 Schmidt, B., Roberts, R.S., Davis, P.G., Doyle, L.W., Asztalos, E.V., Opie, G., et al. Prediction of late death or disability at age 5 years using a count of 3 neonatal morbidities in very low birth weight infants. J Pediatr 167 (2015), 982–986 e2.
3. 3 Smith, V.C., Zupancic, J.A., McCormick, M.C., Croen, L.A., Greene, J., Escobar, G.J., et al. Rehospitalization in the first year of life among infants with bronchopulmonary dysplasia. J Pediatr 144 (2004), 799–803.
4. 4 D'Angio, C.T., Ambalavanan, N., Carlo, W.A., McDonald, S.A., Skogstrand, K., Hougaard, D.M., et al. Blood cytokine profiles associated with distinct patterns of bronchopulmonary dysplasia among extremely low birth weight infants. J Pediatr 174 (2016), 45–51 e5.
5. 5 Guss, A.M., Roeselers, G., Newton, I.L., Young, C.R., Klepac-Ceraj, V., Lory, S., et al. Phylogenetic and metabolic diversity of bacteria associated with cystic fibrosis. ISME J 5 (2011), 20–29.
6. 6 Sze, M.A., Dimitriu, P.A., Suzuki, M., McDonough, J.E., Campbell, J.D., Brothers, J.F., et al. Host response to the lung microbiome in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 192 (2015), 438–445.
7. 7 Huang, Y.J., Nariya, S., Harris, J.M., Lynch, S.V., Choy, D.F., Arron, J.R., et al. The airway microbiome in patients with severe asthma: associations with disease features and severity. J Allergy Clin Immunol 136 (2015), 874–884.
8. 8 Yu, W., Yuan, X., Xu, X., Ding, R., Pang, L., Liu, Y., et al. Reduced airway microbiota diversity is associated with elevated allergic respiratory inflammation. Ann Allergy Asthma Immunol 115 (2015), 63–68.
9. 9 Mai, V., Young, C.M., Ukhanova, M., Wang, X., Sun, Y., Casella, G., et al. Fecal microbiota in premature infants prior to necrotizing enterocolitis. PLoS ONE, 6, 2011, e20647.
10. 10 Ibrahim, O.M., Polk, R.E., Antimicrobial use metrics and benchmarking to improve stewardship outcomes: methodology, opportunities, and challenges. Infect Dis Clin North Am 28 (2014), 195–214.
11. 11 Ezz-Eldin, Z.M., Hamid, T.A., Youssef, M.R., Nabil Hel, D., Clinical Risk Index for Babies (CRIB II) scoring system in prediction of mortality in premature babies. J Clin Diagn Res 9 (2015), SC8–11.
12. 12 Duryea, E.L., Hawkins, J.S., McIntire, D.D., Casey, B.M., Leveno, K.J., A revised birth weight reference for the United States. Obstet Gynecol 124 (2014), 16–22.
13. 13 Stoll, B.J., Hansen, N., Fanaroff, A.A., Wright, L.L., Carlo, W.A., Ehrenkranz, R.A., et al. Late-onset sepsis in very low birth weight neonates: the experience of the NICHD Neonatal Research Network. Pediatrics 110 (2002), 285–291.
14. 14 Ehrenkranz, R.A., Walsh, M.C., Vohr, B.R., Jobe, A.H., Wright, L.L., Fanaroff, A.A., et al. Validation of the National Institutes of Health consensus definition of bronchopulmonary dysplasia. Pediatrics 116 (2005), 1353–1360.
15. 15 Novitsky, A., Tuttle, D., Locke, R.G., Saiman, L., Mackley, A., Paul, D.A., Prolonged early antibiotic use and bronchopulmonary dysplasia in very low birth weight infants. Am J Perinatol 32 (2015), 43–48.
16. 16 Zhou, Y., Shan, G., Sodergren, E., Weinstock, G., Walker, W.A., Gregory, K.E., Longitudinal analysis of the premature infant intestinal microbiome prior to necrotizing enterocolitis: a case- control study. PLoS ONE, 10, 2015, e0118632.
17. 17 Lohmann, P., Luna, R.A., Hollister, E.B., Devaraj, S., Mistretta, T.A., Welty, S.E., et al. The airway microbiome of intubated premature infants: characteristics and changes that predict the development of bronchopulmonary dysplasia. Pediatr Res 76 (2014), 294–301.
18. 18 Shilts, M.H., Rosas-Salazar, C., Tovchigrechko, A., Larkin, E.K., Torralba, M., Akopov, A., et al. Minimally invasive sampling method identifies differences in taxonomic richness of nasal microbiomes in young infants associated with mode of delivery. Microb Ecol 71 (2016), 233–242.
19. 19 Heida, F.H., van Zoonen, A.G., Hulscher, J.B., Te Kiefte, B.J., Wessels, R., Kooi, E.M., et al. A necrotizing enterocolitis-associated gut microbiota is present in the meconium: results of a prospective study. Clin Infect Dis 62 (2016), 863–870.
20. 20 de Man, P., Verhoeven, B.A., Verbrugh, H.A., Vos, M.C., van den Anker, J.N., An antibiotic policy to prevent emergence of resistant bacilli. Lancet 355 (2000), 973–978.
21. 21 Cotten, C.M., Taylor, S., Stoll, B., Goldberg, R.N., Hansen, N.I., Sanchez, P.J., et al. Prolonged duration of initial empirical antibiotic treatment is associated with increased rates of necrotizing enterocolitis and death for extremely low birth weight infants. Pediatrics 123 (2009), 58–66.
22. 22 Kuppala, V.S., Meinzen-Derr, J., Morrow, A.L., Schibler, K.R., Prolonged initial empirical antibiotic treatment is associated with adverse outcomes in premature infants. J Pediatr 159 (2011), 720–725.
23. 23 Lin, H.C., Su, B.H., Chen, A.C., Lin, T.W., Tsai, C.H., Yeh, T.F., et al. Oral probiotics reduce the incidence and severity of necrotizing enterocolitis in very low birth weight infants. Pediatrics 115 (2005), 1–4.
24. 24 Dilli, D., Aydin, B., Fettah, N.D., Ozyazici, E., Beken, S., Zenciroglu, A., et al. The ProPre-Save Study: effects of probiotics and prebiotics alone or combined on necrotizing enterocolitis in very low birth weight infants. J Pediatr 166 (2015), 545–551 e1.
25. 25 Cantey, J.B., Optimizing the use of antibacterial agents in the neonatal period. Paediatr Drugs 18 (2016), 109–122.
26. 26 Cantey, J.B., Wozniak, P.S., Pruszynski, J., Sanchez, P.J., Reducing unnecessary antibiotic use in the neonatal intensive care unit (SCOUT): a prospective interrupted time-series study. Lancet Infect Dis 16 (2016), 1178–1184.
27. 27 Sjoding, M.W., Luo, K., Miller, M.A., Iwashyna, T.J., When do confounding by indication and inadequate risk adjustment bias critical care studies? A simulation study. Crit Care, 19, 2015, 195.
28. 28 Cordero, L., Ayers, L.W., Duration of empiric antibiotics for suspected early-onset sepsis in extremely low birth weight infants. Infect Control Hosp Epidemiol 24 (2003), 662–666.
29. 29 Spitzer, A.R., Kirkby, S., Kornhauser, M., Practice variation in suspected neonatal sepsis: a costly problem in neonatal intensive care. J Perinatol 25 (2005), 265–269.
30. 30 Lal, C.V., Travers, C., Aghai, Z.H., Eipers, P., Jilling, T., Halloran, B., et al. The airway microbiome at birth. Sci Rep, 6, 2016, 31023.
31. 31 Payne, N.R., LaCorte, M., Karna, P., Chen, S., Finkelstein, M., Goldsmith, J.P., et al. Reduction of bronchopulmonary dysplasia after participation in the Breathsavers Group of the Vermont Oxford Network Neonatal Intensive Care Quality Improvement Collaborative. Pediatrics 118:Suppl 2 (2006), S73–7.